Sangamo BioSciences | SGMO - Marktkapitalisierung

Aktienkurs
0.25
Täglich Wechseln
-0.01 -4.09%
Monatlich
-38.64%
Jährlich
-65.04%
Q2 Prognose
0.24




Marktkapitalisierung Veränderung Datum
Alaunos Therapeutics USD 5M 5M 2025-09
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Alterity Therapeutics Limited AUD 30M 26M 2026-04
Amgen USD 176.25B 24.32B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Cipla INR 1.22T 6.47B 2025-12
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 144.67M 7.17M 2025-12
CSL USD 55.89B 20.42B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 500.24B 67.44B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
Merck USD 261.26B 51.62B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12